0001415889-23-000670.txt : 20230109 0001415889-23-000670.hdr.sgml : 20230109 20230109161226 ACCESSION NUMBER: 0001415889-23-000670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEELE GLENN JR MD PHD CENTRAL INDEX KEY: 0001269131 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23518220 MAIL ADDRESS: STREET 1: 250 TECHNOLOGY PARK CITY: LAKE MARY STATE: FL ZIP: 32746-6232 FORMER NAME: FORMER CONFORMED NAME: STEELE GLENN JR MD DATE OF NAME CHANGE: 20031105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-01092023_090113.xml X0306 4 2023-01-05 0001070081 PTC THERAPEUTICS, INC. PTCT 0001269131 STEELE GLENN JR MD PHD C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 true false false false Common Stock 2023-01-05 4 A 0 4000 0 A 10500 D Stock Option (Right to Buy) 39.42 2023-01-05 4 A 0 10000 0 A 2033-01-04 Common Stock 10000 10000 D Restricted stock units granted on January 5, 2023 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 6, 2023 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 5, 2024. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death. This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2023-01-09